Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ZIVO Bioscience Inc.

    OTC: ZIVO · Real-Time Price · USD
    15.99
    0.24 (1.52%)
    At close: Apr 04, 2025, 3:10 PM

    ZIVO Bioscience Statistics

    Share Statistics

    ZIVO Bioscience has 3.76M shares outstanding. The number of shares has increased by 35.34% in one year.

    Shares Outstanding

    n/a
    		 3.76M

    Shares Change (YoY)

    n/a
    		 35.34%

    Shares Change (QoQ)

    n/a
    		 11.68%

    Owned by Institutions (%)

    n/a
    		 13.11%

    Shares Floating

    n/a
    		 1.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 32

    FTD / Avg. Volume

    n/a
    		 3.95%

    Short Selling Information

    The latest short interest is 35.47K, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 35.47K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 2.72%

    Short Ratio (days to cover)

    n/a
    		 6.65

    Valuation Ratios

    The PE ratio is -5.48 and the forward PE ratio is -15.72. ZIVO Bioscience's PEG ratio is 0.37.

    PE Ratio

    n/a
    		 -5.48

    Forward PE

    n/a
    		 -15.72

    PS Ratio

    n/a
    		 466.38

    Forward PS

    n/a
    		 29.3

    PB Ratio

    n/a
    		 48.02

    P/FCF Ratio

    n/a
    		 -17

    PEG Ratio

    n/a
    		 0.37
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ZIVO Bioscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.8, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 0.8

    Quick Ratio

    n/a
    		 0.8

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 -582.5

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $22,460

    Profits Per Employee

    n/a
    		 $-1,912,119.43

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0.1

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 97.12% in the last 52 weeks. The beta is 0.11, so ZIVO Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.11

    52-Week Price Change

    n/a
    		 97.12%

    50-Day Moving Average

    n/a
    		 18.88

    200-Day Moving Average

    n/a
    		 15.94

    Relative Strength Index (RSI)

    n/a
    		 33.36

    Average Volume (20 Days)

    n/a
    		 810

    Income Statement

    In the last 12 months, ZIVO Bioscience had revenue of 157.22K and earned -13.38M in profits. Earnings per share was -3.92.

    Revenue

    n/a
    		 157.22K

    Gross Profit

    n/a
    		 48.95K

    Operating Income

    n/a
    		 -13.36M

    Net Income

    n/a
    		 -13.38M

    EBITDA

    n/a
    		 -13.36M

    EBIT

    n/a
    		 -13.36M

    Earnings Per Share (EPS)

    n/a
    		 -3.92
    Full Income Statement

    Balance Sheet

    The company has 1.54M in cash and 254.36K in debt, giving a net cash position of 1.29M.

    Cash & Cash Equivalents

    n/a
    		 1.54M

    Total Debt

    n/a
    		 254.36K

    Net Cash

    n/a
    		 1.29M

    Retained Earnings

    n/a
    		 -136.97M

    Total Assets

    n/a
    		 1.64M

    Working Capital

    n/a
    		 -406.38K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.31M and capital expenditures 0, giving a free cash flow of -4.31M.

    Operating Cash Flow

    n/a
    		 -4.31M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.31M

    FCF Per Share

    n/a
    		 -1.26
    Full Cash Flow Statement

    Margins

    Gross margin is 31.14%, with operating and profit margins of -8498.85% and -8513.44%.

    Gross Margin

    n/a
    		 31.14%

    Operating Margin

    n/a
    		 -8498.85%

    Pretax Margin

    n/a
    		 -8513.44%

    Profit Margin

    n/a
    		 -8513.44%

    EBITDA Margin

    n/a
    		 -8498.85%

    EBIT Margin

    n/a
    		 -8498.85%

    FCF Margin

    n/a
    		 -2743.61%

    Dividends & Yields

    ZIVO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ZIVO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 27, 2023. It was a backward split with a ratio of 1:6.

    Last Split Date

    n/a
    		 Oct 27, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:6

    Scores

    Altman Z-Score

    n/a
    		 -125.95

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist